...
首页> 外文期刊>Journal of Medicinal Chemistry >Substituted 2-Acylaminocycloalkylthiophene-3-carboxylic Acid Arylamides as Inhibitors of the Calcium-Activated Chloride Channel Transmembrane Protein 16A (TMEM16A)
【24h】

Substituted 2-Acylaminocycloalkylthiophene-3-carboxylic Acid Arylamides as Inhibitors of the Calcium-Activated Chloride Channel Transmembrane Protein 16A (TMEM16A)

机译:取代的2-酰氨环环烷基硫戊烯-3-羧酸芳基胺作为钙激活氯通道跨膜蛋白16a的抑制剂(tmem16a)

获取原文
获取原文并翻译 | 示例
           

摘要

Transmembrane protein 16A (TMEM16A), also called anoctamin 1 (ANO1), is a calcium-activated chloride channel expressed widely mammalian cells, including epithelia, vascular smooth muscle tissue, electrically excitable cells, and some tumors. TMEM16A inhibitors have been proposed for treatment of disorders of epithelial fluid and mucus secretion, hypertension, asthma, and possibly cancer. Herein we report, by screening, the discovery of 2-acylaminocycloalkylthiophene-3-carboxylic acid arylamides (AACTs) as inhibitors of TMEM16A and analysis of 48 synthesized analogs (10ab-10bw) of the original AACT compound (10aa). Structure activity studies indicated the importance of benzene substituted as 2- or 4-methyl, or 4-fluoro, and defined the significance of thiophene substituents and size of the cycloalkylthiophene core. The most potent compound (10bm), which contains an unusual bromodifluoroacetamide at the thiophene 2-position, had IC50 of similar to 30 nM, similar to 3.6-fold more potent than the most potent previously reported TMEM16A inhibitor 4 (Ani9), and >10-fold improved metabolic stability. Direct and reversible inhibition of TMEM16A by 10bm was demonstrated by patch-clamp analysis. AACTs may be useful as pharmacological tools to study TMEM16A function and as potential drug development candidates.
机译:跨膜蛋白16A(TMEM16A),也称为Anoctamin 1(AnO1),是钙激活的氯化物通道,表达广泛的哺乳动物细胞,包括上皮细胞,血管平滑肌组织,电激发细胞和一些肿瘤。已经提出了TMEM16A抑制剂用于治疗上皮液和粘液分泌,高血压,哮喘和可能癌症的疾病。在此,通过筛选来报告2-酰氨基环烷烯-3-羧酸芳基胺-3-羧酸芳基酰胺(ACT)作为TMEM16a的抑制剂和48个合成的类似物(10ab-10bw)的原始AACT化合物(10aa)的分析。结构活性研究表明,苯取代为2-或4-甲基,或4-氟,并限定了噻吩取代基的意义和环烷基噻吩核的尺寸。最有效的化合物(10bm),其含有在噻吩2-位置的不寻常的溴二氟乙酰胺,其具有与30nm相似的IC50,类似于比以前报告的TMEM16A抑制剂4(ANI9)的最有效的3.6倍。 10倍改善的代谢稳定性。通过Patch-Clamp分析证明了通过10Bm的直接和可逆抑制TMEM16A。 AACTS可用作研究TMEM16A功能和潜在的药物开发候选者的药理学工具。

著录项

  • 来源
    《Journal of Medicinal Chemistry》 |2017年第11期|共10页
  • 作者单位

    San Francisco State Univ Dept Chem &

    Biochem San Francisco CA 94132 USA;

    Univ Calif San Francisco Dept Med San Francisco CA 94143 USA;

    San Francisco State Univ Dept Chem &

    Biochem San Francisco CA 94132 USA;

    Ist Giannina Gaslini UOC Genet Med I-16148 Genoa Italy;

    Telethon Inst Genet &

    Med TIGEM I-80078 Pozzuoli NA Italy;

    San Francisco State Univ Dept Chem &

    Biochem San Francisco CA 94132 USA;

    San Francisco State Univ Dept Chem &

    Biochem San Francisco CA 94132 USA;

    Univ Calif San Francisco Dept Med San Francisco CA 94143 USA;

    San Francisco State Univ Dept Chem &

    Biochem San Francisco CA 94132 USA;

    Univ Calif San Francisco Dept Med San Francisco CA 94143 USA;

    Univ Calif San Francisco Dept Med San Francisco CA 94143 USA;

    San Francisco State Univ Dept Chem &

    Biochem San Francisco CA 94132 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号